“…Its capacity to function as an antioxidant, anti‐inflammatory agent, and direct inhibitor of tumors, makes it a promising avenue for cancer therapy, demonstrating effectiveness against diverse cancer types in experimental studies (Ren et al, 2021). There are some evidence that have highlighted the ferroptosis suppressive function of resveratrol in human diseases such as ischemia–reperfusion injury (Liu, An, et al, 2022; Liu, Qi, et al, 2022; Liu, Wei, & Li, 2022; Liu, Wu, et al, 2022; Liu, Zhang, et al, 2022; Wang, Li, Wang, Chen, & Goh, 2023; Wang, Li, Wang, Chen, Li, et al, 2023; Wang, Li, Wang, Zhu, Liu, et al, 2023; Wang, Lin, Huang, Liu, Chen, et al, 2023; Wang, Liu, Li, Zha, Chen, et al, 2023; Wang, Shen, Lian, Deng, Qu, et al, 2023; Wang, Tan, Zhang, Wu, & Shi, 2023; Wang, Wan, Peng, Zhao, Bai, & Hu, 2023), heart failure (Zhang et al, 2023), and oxygen–glucose deprivation/reoxygenation (Zhu et al, 2022), due to its activatory effect on sirtuins (as master regulators of antioxidative response) (Wang, Li, Wang, Chen, & Goh, 2023; Wang, Li, Wang, Chen, Li, et al, 2023; Wang, Li, Wang, Zhu, Liu, et al, 2023; Wang, Lin, Huang, Liu, Chen, et al, 2023; Wang, Liu, Li, Zha, Chen, et al, 2023; Wang, Shen, Lian, Deng, Qu, et al, 2023; Wang, Tan, Zhang, Wu, & Shi, 2023; Wang, Wan, Peng, Zhao, Bai, & Hu, 2023; Zhang et al, 2023). However, induction of ferroptosis by resveratrol in tumors seems to be promising as cancer cells are more dependent on iron.…”